Hanmi Pharm. Co., Ltd. (128940.KS)
KRW 269500.0
(-1.46%)
KRW 269500.0
(-1.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1490.88 Billion | 1331.54 Billion | 1203.18 Billion | 1075.85 Billion | 1113.64 Billion | 1015.96 Billion |
| Cost of Revenue | 655.03 Billion | 612.99 Billion | 570.43 Billion | 494.93 Billion | 481.16 Billion | 475.04 Billion |
| Gross Profit | 835.85 Billion | 718.55 Billion | 632.75 Billion | 580.91 Billion | 632.48 Billion | 540.91 Billion |
| Operating Expenses | 610.97 Billion | 560.46 Billion | 507.33 Billion | 531.94 Billion | 528.6 Billion | 457.34 Billion |
| Selling, General and Administrative Expenses | 418.74 Billion | 233.63 Billion | 213.37 Billion | 181.94 Billion | 190.95 Billion | 169.76 Billion |
| Research and Development Expenses | 192.22 Billion | 154.31 Billion | 146.02 Billion | 212.38 Billion | 194.28 Billion | 165.9 Billion |
| Other Expenses | - | 172.51 Billion | 147.92 Billion | 137.61 Billion | 143.35 Billion | 121.67 Billion |
| Cost and Expenses | 1266 Billion | 1173.45 Billion | 1077.76 Billion | 1026.87 Billion | 1009.77 Billion | 932.38 Billion |
| Operating Income | 224.88 Billion | 158.09 Billion | 125.41 Billion | 48.97 Billion | 103.87 Billion | 83.57 Billion |
| Interest Expense | 28.5 Billion | 22.64 Billion | 16.57 Billion | 24.86 Billion | 24.99 Billion | 19.41 Billion |
| Income Tax Expense | 28.6 Billion | 19.45 Billion | 22.21 Billion | 4.84 Billion | 19.4 Billion | 16.19 Billion |
| Earnings before Tax | 195.26 Billion | 121.01 Billion | 103.69 Billion | 22.13 Billion | 83.26 Billion | 50.35 Billion |
| Net Income | 146.23 Billion | 82.79 Billion | 67.02 Billion | 17.28 Billion | 52.1 Billion | 34.15 Billion |
| Earnings Per Share Basic | 11.52 Thousand | 6517.20 | 5269.74 | 1357.83 | 4008.72 | 2735.74 |
| Earnings Per Share Diluted | 11.52 Thousand | 6517.20 | 5269.74 | 1357.83 | 4008.72 | 2735.74 |
| Weighted Average Shares Outstanding | 12.69 Million | 12.7 Million | 12.71 Million | 12.73 Million | 12.99 Million | 12.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.69 Million | 12.7 Million | 12.71 Million | 12.73 Million | 12.99 Million | 12.48 Million |
| Gross Margin | 0.56 | 0.54 | 0.53 | 0.54 | 0.57 | 0.53 |
| EBIT Margin | 0.22 | 0.19 | 0.18 | 0.11 | 0.15 | 0.12 |
| Profit Margin | 0.10 | 0.06 | 0.06 | 0.02 | 0.05 | 0.03 |
| EBITDA | 323.33 Billion | 249.03 Billion | 209.36 Billion | 108.33 Billion | 163.67 Billion | 116.88 Billion |
| Earnings Before Tax Margin | 0.15 | 0.12 | 0.10 | 0.05 | 0.09 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 362.07 Billion | 378.13 Billion | 403.68 Billion | 422.35 Billion | 1490.88 Billion | 364.61 Billion |
| Cost of Revenue | - | 171.45 Billion | 177.19 Billion | 176.54 Billion | 655.03 Billion | 165.76 Billion |
| Gross Profit | 362.07 Billion | 206.67 Billion | 226.48 Billion | 245.8 Billion | 835.85 Billion | 198.84 Billion |
| Operating Expenses | 311.1 Billion | 148.57 Billion | 149.84 Billion | 170.76 Billion | 610.97 Billion | -141.33 Billion |
| Selling, General and Administrative Expenses | - | 103.03 Billion | 108.7 Billion | 109.57 Billion | - | 141.33 Billion |
| Research and Development Expenses | - | 45.53 Billion | 41.13 Billion | 61.93 Billion | - | 40.04 Billion |
| Other Expenses | -311.1 Billion | -320.02 Billion | -327.03 Billion | 750.16 Million | 12.39 Billion | -282.66 Billion |
| Cost and Expenses | 311.1 Billion | 320.02 Billion | 327.03 Billion | 347.3 Billion | 1266 Billion | 165.76 Billion |
| Operating Income | 50.97 Billion | 58.1 Billion | 76.64 Billion | 75.04 Billion | 224.88 Billion | 57.51 Billion |
| Interest Expense | - | - | 6.54 Billion | 6.9 Billion | 28.5 Billion | 7 Billion |
| Income Tax Expense | 5.23 Billion | 6.91 Billion | 11.77 Billion | 20.5 Billion | 28.6 Billion | -4.25 Billion |
| Earnings before Tax | 40.19 Billion | 53.97 Billion | 74.98 Billion | 56.9 Billion | 195.26 Billion | 56.28 Billion |
| Net Income | 34.95 Billion | 40.27 Billion | 55 Billion | 34.39 Billion | 146.23 Billion | 54.7 Billion |
| Earnings Per Share Basic | 2756.66 | 3175.86 | 4336.82 | 2764.48 | - | 4311.01 |
| Earnings Per Share Diluted | 2756.66 | 3175.86 | 4336.82 | 2764.48 | - | 4311.01 |
| Weighted Average Shares Outstanding | 12.68 Million | 12.68 Million | 12.68 Million | 12.44 Million | 12.69 Million | 12.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.68 Million | 12.68 Million | 12.68 Million | 12.44 Million | 12.69 Million | 12.69 Million |
| Gross Margin | 1.00 | 0.55 | 0.56 | 0.58 | 0.56 | 0.55 |
| EBIT Margin | 0.14 | 0.22 | 0.25 | 0.24 | - | 0.55 |
| Profit Margin | 0.10 | 0.11 | 0.14 | 0.08 | 0.10 | 0.15 |
| EBITDA | 50.97 Billion | 82.45 Billion | 100.85 Billion | 99.66 Billion | - | 198.84 Billion |
| Earnings Before Tax Margin | 0.14 | 0.15 | 0.19 | 0.18 | 0.15 | 0.16 |
6741
4991
PDLB
RHC
SSVC
MANAKCOAT